BlackRock Group’s bluebird bio BLUE Stock Holding History

BlackRock Group’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.8M	Sell	2,248 -3,766	-63%	-$2.99M	﹤0.01%	1838
2016 Q3	$5.28M	Buy	6,014 +4,313	+254%	+$3.12M	﹤0.01%	1090
2016 Q2	$954K	Sell	1,701 -204	-11%	-$116K	﹤0.01%	1994
2016 Q1	$1.05M	Buy	1,905 +193	+11%	+$119K	﹤0.01%	1925
2015 Q4	$1.43M	Buy	1,712 +54	+3%	+$53.9K	﹤0.01%	1672
2015 Q3	$1.84M	Buy	1,658 +248	+18%	+$452K	﹤0.01%	1542
2015 Q2	$3.08M	Buy	1,410 +495	+54%	+$1.01M	﹤0.01%	1345
2015 Q1	$1.43M	Buy	915 +481	+111%	+$635K	﹤0.01%	1656
2014 Q4	$515K	Buy	434 +403	+1,300%	+$269K	﹤0.01%	2220
2014 Q3	$15K	Buy	+31	New	+$14.3K	﹤0.01%	2769
2014 Q2	–	Sell	-2,826	Closed	-$832K	–	2823
2014 Q1	$832K	Hold	2,826	–	–	﹤0.01%	2065
2013 Q4	$768K	Sell	2,826 -44	-2%	-$12.3K	﹤0.01%	2085
2013 Q3	$1M	Buy	+2,870	New	+$1.07M	﹤0.01%	1907

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

BlackRock Group's BLUE Position: Q4 2016 in Review

BlackRock Group reduced its bluebird bio (BLUE) stake by 63% in Q4 2016, selling an estimated $2.99M and leaving 2,248 shares worth $1.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1838.

BlackRock Group first reported a position in BLUE in Q3 2013 and has held it in 13 quarters since. The position peaked at $5.28M in Q3 2016. 199 funds tracked by Wall St. Rank hold BLUE as of Q4 2016.

BlackRock Group held 2,248 shares of bluebird bio worth $1.8M as of Q4 2016.
BlackRock Group sold 3,766 bluebird bio shares in Q4 2016, an estimated $2.99M.
bluebird bio made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1838 holding.
BlackRock Group first reported a position in bluebird bio in Q3 2013 and has held it in 13 quarters since.
BlackRock Group's bluebird bio position peaked at $5.28M in Q3 2016.
199 funds tracked by Wall St. Rank held bluebird bio as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.